MarginsXMarginsX
Home › Markets › Health Care › AZTR

Azitra Inc (AZTR)

AZTR trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.6270
+3.06% on the day
Market cap
$3.8M
Nano cap
Revenue · 2025
$0
-100.0% on 2024
Net income · 2025
-$11.0M

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1701478/000170147826000013/0001701478-26-000013-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerAZTR on NYSE
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryNot reported by the screener
IPO year2023
SEC CIK0001701478
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$0
Net income-$11.0M
Operating income-$11.0M
Net marginNeeds revenue and net income
Operating marginOperating income not reported
Revenue growth-100.0%
Cash$2.1M
Total assets$5.0M
P/E (computed)Net income was not positive
P/S (computed)Needs market cap and revenue

Warning signs

Cash runway
3.9 months
$3.8M cash at September 30, 2026
Share count, 1 year
+493.9%
2025-11-11 to 2026-11-12 · +100092.0% over 3 years
Going-concern doubt
Yes
10-Q filed November 12, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions and events create substantial doubt about the ability of the Company to continue as a going concern for twelve months from the date that the financial statements are available to be issued."
10-Q 2026-11-12
Cash and burn$3.8M cash; operating cash flow -$2.9M a quarter.Report 2026-09-30
Shares outstanding6,060,435 (2026-11-12); 10,204,938 a year earlier; 12,097,643 three years earlier. 1y figure adjusted for splits (1-for-10 overall); 3y figure adjusted for splits (1-for-2000 overall).Cover page 2026-11-12
Reverse splits, 3 years3; latest 1-for-10 on 2026-10-26Source 2026-10-26
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-09-28
Exchange deficiency notices, 12 months2 (8-K item 3.01)8-K 2026-03-13
AuditorGrassi & Co., CPAs, P.C., Jericho, New York, United StatesPCAOB Form AP 2026-03-09
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$2.9M-$2.9M$3.8MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2026
2026-06-30
Not filed-$3.3M-$3.3M$6.7MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q1 2026
2026-03-31
Not filed-$3.9M-$2.5M$10.1MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q4 2025
2025-12-31
$0-$2.2M-$2.9M$2.1MNo debt tags$010-K 2026-02-27
Q3 2025
2025-09-30
$0-$2.8M-$2.4M$1.4MNo debt tagsNeeds four quarters10-Q 2025-11-12
Q2 2025
2025-06-30
$0-$2.9M-$2.8M$1.0MNo debt tagsNeeds four quarters10-Q 2025-08-11
Q1 2025
2025-03-31
Not filed-$3.1M-$3.1M$3.2MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q4 2024
2024-12-31
$0-$2.4M-$2.6M$4.6MNo debt tags$8K10-K 2026-02-27

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-09-28
Latest annual report10-K2026-02-27
Latest quarterly / interim10-Q2026-11-12
Latest current report8-K2026-11-12
Latest proxyDEFA14A2026-06-04

Source: SEC EDGAR submissions feed, 242 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-17.1%
1 month-15.6%
3 months-56.6%
Year to date-77.1%
1 year-82.4%
From 52-week high-84.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
XTLBXTL Biopharmaceuticals Ltd.$1.54-3.75%$3.8M
GELSGelteq Limited$0.3589-5.63%$3.8M
IMNNImunon Inc.$0.5940-5.56%$3.9M
TRAWTraws Pharma Inc.$0.2600+3.59%$4.0M
XBIOXenetic Biosciences Inc.$1.49-10.24%$3.5M
SILOSilo Pharma Inc.$1.57-14.40%$3.4M
BGMSBio Green Med Solution Inc.$0.6502+1.55%$4.3M
KPRXKiora Pharmaceuticals Inc.$0.9820-20.16%$4.3M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier